AU2001283563A1 - Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent - Google Patents
Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agentInfo
- Publication number
- AU2001283563A1 AU2001283563A1 AU2001283563A AU8356301A AU2001283563A1 AU 2001283563 A1 AU2001283563 A1 AU 2001283563A1 AU 2001283563 A AU2001283563 A AU 2001283563A AU 8356301 A AU8356301 A AU 8356301A AU 2001283563 A1 AU2001283563 A1 AU 2001283563A1
- Authority
- AU
- Australia
- Prior art keywords
- dosage forms
- pharmaceutical dosage
- oral pharmaceutical
- antiarrhythmic agent
- pulsatile delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09639584 | 2000-08-14 | ||
US09/639,584 US6500457B1 (en) | 2000-08-14 | 2000-08-14 | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
PCT/US2001/041712 WO2002013794A1 (en) | 2000-08-14 | 2001-08-14 | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001283563A1 true AU2001283563A1 (en) | 2002-02-25 |
Family
ID=24564715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001283563A Abandoned AU2001283563A1 (en) | 2000-08-14 | 2001-08-14 | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
Country Status (4)
Country | Link |
---|---|
US (2) | US6500457B1 (en) |
EP (1) | EP1311247A4 (en) |
AU (1) | AU2001283563A1 (en) |
WO (1) | WO2002013794A1 (en) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
IT1318625B1 (en) * | 2000-07-14 | 2003-08-27 | Roberto Valducci | ORAL SOLID PHARMACEUTICAL FORMULATIONS WITH MULTI-PHASE RELEASE - EMPLOYEE. |
AU2002256092C1 (en) * | 2001-04-05 | 2009-10-15 | Collagenex Pharmaceuticals, Inc. | Controlled delivery of tetracycline compounds and tetracycline derivatives |
SE0101329D0 (en) * | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | Pharmaceutical formulation |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
EP1396263A1 (en) * | 2002-08-09 | 2004-03-10 | Warner-Lambert Company | Film coating for tablets and caplets |
MY148805A (en) * | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
PL1615622T3 (en) | 2003-04-07 | 2012-12-31 | Supernus Pharmaceuticals Inc | Once daily formulations of doxycyclines |
US8802139B2 (en) | 2003-06-26 | 2014-08-12 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US20050220873A1 (en) * | 2004-04-02 | 2005-10-06 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist |
US8007827B2 (en) * | 2004-04-02 | 2011-08-30 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties |
US20050226927A1 (en) * | 2004-04-02 | 2005-10-13 | Impax Laboratories, Inc. | Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist |
US20060105044A1 (en) | 2004-05-20 | 2006-05-18 | Singh Bramah N | Sustained release formulations of sotalol |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
PL204079B1 (en) * | 2004-08-12 | 2009-12-31 | Inst Farmaceutyczny | Oral solid tamsulozine hydrochloride preparation with prolonged release and method for its manufacture |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US20060165788A1 (en) * | 2004-09-09 | 2006-07-27 | Wattanaporn Abramowitz | Lercanidipine pH dependent pulsatile release compositions |
US20060165789A1 (en) * | 2004-09-09 | 2006-07-27 | Forest Laboratories, Inc. | Lercanidipine modified release compositions |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
NZ589750A (en) | 2004-10-21 | 2012-07-27 | Aptalis Pharmatech Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
TW200626185A (en) * | 2004-12-17 | 2006-08-01 | Bpsi Holdings Inc | Enteric film coating composition containing entericpolymer micronized with detackifier |
CA2605185A1 (en) * | 2005-04-06 | 2006-10-12 | Mallinckrodt Inc. | Matrix-based pulse release pharmaceutical formulation |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
AU2013273835B2 (en) * | 2005-05-02 | 2016-07-07 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
JP5095615B2 (en) | 2005-06-27 | 2012-12-12 | バリアント・インターナショナル・(バルバドス)・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ | Modified release of bupropion salt |
CN101687094B (en) * | 2005-09-06 | 2012-09-26 | 谢拉杰克特股份有限公司 | Solid solution perforator containing drug particle and/or drug-adsorbed particles |
CN101374507A (en) * | 2005-10-14 | 2009-02-25 | H.隆德贝克有限公司 | Stable pharmaceutical formulations containing escitalopram and bupropion |
JP2009511606A (en) * | 2005-10-14 | 2009-03-19 | ハー・ルンドベック・アクチエゼルスカベット | Methods of treating central nervous system disorders using a low-dose combination of escitalopram and bupropion |
US10064828B1 (en) * | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
ES2531215T3 (en) * | 2006-01-27 | 2015-03-11 | Aptalis Pharmatech Inc | Drug delivery systems comprising a weakly basic serotonin 5-HT3 selective blocking agent and organic acids |
EP1976492B8 (en) * | 2006-01-27 | 2018-07-04 | Adare Pharmaceuticals, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
US9561188B2 (en) | 2006-04-03 | 2017-02-07 | Intellipharmaceutics Corporation | Controlled release delivery device comprising an organosol coat |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
JP2010534721A (en) * | 2007-07-27 | 2010-11-11 | ディポメド,インコーポレイティド | Pulse type gastric retentive preparation |
TW200940110A (en) * | 2008-02-22 | 2009-10-01 | Astrazeneca Ab | Pharmaceutical formulation comprising oxabispidines |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
US20090253801A1 (en) * | 2008-04-07 | 2009-10-08 | Shah Manish J | Novel Antiarrhythmic Drug Formulations |
FR2930147B1 (en) * | 2008-04-18 | 2013-02-08 | Flamel Tech Sa | SOLID ORAL FORM WITH A DOUBLE RELEASE PROFILE |
WO2010014952A2 (en) | 2008-07-31 | 2010-02-04 | Clarke Mosquito Control Products, Inc. | Extended release tablet and method for making and using same |
JP5698683B2 (en) | 2009-03-09 | 2015-04-08 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | Pulsed release composition of therapeutic agent |
US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
JP5309262B2 (en) | 2009-12-02 | 2013-10-09 | アプタリス ファーマ リミテッド | Fexofenadine microcapsule and composition containing the same |
BR112014020186A8 (en) | 2012-02-22 | 2017-07-11 | Duchesnay Inc | FORMULATION OF DOXYLAMINE AND PYRIDOXINE AND/OR THEIR METABOLITES OR SALTS |
SG11201507450TA (en) | 2013-03-14 | 2015-10-29 | Redhill Biopharma Ltd | Antiemetic extended release solid dosage forms |
US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
SI2970101T1 (en) | 2013-03-14 | 2018-09-28 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various deseases |
MX366760B (en) | 2013-07-22 | 2019-07-23 | Duchesnay Inc | Composition for the management of nausea and vomiting. |
ES2753361T3 (en) | 2014-02-24 | 2020-04-08 | Alkermes Pharma Ireland Ltd | Sulfonamide and sulfinamide fumarate prodrugs and their use in the treatment of various diseases |
UA121209C2 (en) | 2014-03-11 | 2020-04-27 | Редгіл Байофарма Лтд. | Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms |
US9795571B2 (en) | 2014-09-19 | 2017-10-24 | The Procter & Gamble Company | Pulsed release phenylephrine dosage forms |
WO2016077832A2 (en) | 2014-11-14 | 2016-05-19 | Gemphire Therapeutics Inc. | PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS |
US10278930B2 (en) | 2017-03-16 | 2019-05-07 | The Procter & Gamble Company | Method for relieving sinus congestion |
US20190008779A1 (en) * | 2017-05-11 | 2019-01-10 | Gemphire Therapeutics Inc. | Gemcabene compositions and methods of use thereof |
CN109419779B (en) * | 2017-09-04 | 2021-05-25 | 鲁南制药集团股份有限公司 | Sotalol hydrochloride preparation |
US10888524B2 (en) * | 2018-02-05 | 2021-01-12 | Enaltec Pharma Research Pvt. Ltd. | Immediate release tablet of dofetilide |
US11610660B1 (en) | 2021-08-20 | 2023-03-21 | AltaThera Pharmaceuticals LLC | Antiarrhythmic drug dosing methods, medical devices, and systems |
US11696902B2 (en) | 2018-08-14 | 2023-07-11 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
CN113784711A (en) * | 2019-03-12 | 2021-12-10 | 伊登布里奇制药有限公司 | Orally disintegrating tablet comprising glycopyrronium bromide and method for increasing bioavailability |
CN114828832A (en) * | 2019-12-11 | 2022-07-29 | 赢创运营有限公司 | Dosage forms for the treatment and prevention of diseases |
BR112022011055A2 (en) | 2019-12-11 | 2022-08-23 | Evonik Operations Gmbh | DOSAGE FORM FOR USE IN THE TREATMENT OR PREVENTION OF A DISEASE |
US20230040902A1 (en) * | 2019-12-19 | 2023-02-09 | Celltrion Inc. | Pharmaceutical Formulation Comprising Cibenzoline or Salt Thereof |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308126D0 (en) | 1983-03-24 | 1983-05-05 | Bloch M | Pharmaceutical compositions |
US5089526A (en) | 1983-05-23 | 1992-02-18 | Bristol-Myers Company | Antiarrhythmic class III process |
GB8319766D0 (en) | 1983-07-22 | 1983-08-24 | Graham N B | Controlled release device |
US4777049A (en) | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
US4794111A (en) | 1984-05-23 | 1988-12-27 | Bayer Aktiengesellschaft | Dihydropyridine preparations containing β-blockers |
US4863744A (en) | 1984-09-17 | 1989-09-05 | Alza Corporation | Intestine drug delivery |
EP0230654B1 (en) | 1985-12-28 | 1992-03-18 | Sumitomo Pharmaceuticals Company, Limited | Sustained pulsewise release pharmaceutical preparation |
DE3612212A1 (en) | 1986-04-11 | 1987-10-15 | Basf Ag | METHOD FOR PRODUCING SOLID PHARMACEUTICAL FORMS |
US5110597A (en) | 1987-06-25 | 1992-05-05 | Alza Corporation | Multi-unit delivery system |
AU3432689A (en) | 1988-03-24 | 1989-10-16 | Bukh Meditec A/S | Controlled release composition |
US5387419A (en) | 1988-03-31 | 1995-02-07 | The University Of Michigan | System for controlled release of antiarrhythmic agents |
DK469989D0 (en) | 1989-09-22 | 1989-09-22 | Bukh Meditec | PHARMACEUTICAL PREPARATION |
US5017381A (en) | 1990-05-02 | 1991-05-21 | Alza Corporation | Multi-unit pulsatile delivery system |
US5226902A (en) | 1991-07-30 | 1993-07-13 | University Of Utah | Pulsatile drug delivery device using stimuli sensitive hydrogel |
DE69222006T2 (en) | 1991-10-30 | 1998-01-22 | Glaxo Group Ltd | Multilayer compositions containing histamine or serotonin antagonists |
US5456679A (en) | 1992-02-18 | 1995-10-10 | Alza Corporation | Delivery devices with pulsatile effect |
US5209746A (en) | 1992-02-18 | 1993-05-11 | Alza Corporation | Osmotically driven delivery devices with pulsatile effect |
US5260068A (en) | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
US5260069A (en) | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
DK0621032T3 (en) | 1993-04-23 | 2000-10-23 | Novartis Ag | Medicinal product with controlled release |
US5618860A (en) | 1993-05-19 | 1997-04-08 | Ameron International Corporation | Epoxy polysiloxane coating and flooring compositions |
JPH07223970A (en) | 1994-02-10 | 1995-08-22 | Tanabe Seiyaku Co Ltd | Releasing formulation at niche in digestive tract |
AUPM897594A0 (en) | 1994-10-25 | 1994-11-17 | Daratech Pty Ltd | Controlled release container |
US5874475A (en) | 1995-12-21 | 1999-02-23 | Pharmacia & Upjohn Company | Antiarrhythmic (S)-enantiomers of methanesulfonamides |
US5837284A (en) | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
SK18097A3 (en) | 1996-02-28 | 1997-10-08 | American Cyanamid Co | Substituted omega £phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl| £alkyl, alkenyl or alkinyl|amino carboxamides, sulfonamides and phosphonyl amides, pharmaceutical preparation containing them, process for producing them and their use |
US5969017A (en) | 1996-10-31 | 1999-10-19 | Merck & Co., Inc. | Methods of treating or preventing cardiac arrhythmia |
DE69729950T2 (en) * | 1996-11-06 | 2005-07-28 | Wockhardt Europe Ltd. | Released-release drug delivery system for acid labile drugs |
US5914134A (en) | 1997-01-27 | 1999-06-22 | Wockhardt Europe Limited | Process for the pulsatile delivery of diltiazem HCL and product produced thereby |
DE19710213A1 (en) | 1997-03-12 | 1998-09-17 | Basf Ag | Process for the manufacture of solid combination dosage forms |
US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
US5840329A (en) | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
US6083991A (en) | 1997-06-04 | 2000-07-04 | University Of Florida Research Foundation, Inc. | Anti-arrhythmic composition and methods of treatment |
US20010055613A1 (en) * | 1998-10-21 | 2001-12-27 | Beth A. Burnside | Oral pulsed dose drug delivery system |
DK1126826T6 (en) * | 1998-11-02 | 2019-06-24 | Alkermes Pharma Ireland Ltd | Multiparticulate modified release of methylphenidate |
US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
-
2000
- 2000-08-14 US US09/639,584 patent/US6500457B1/en not_active Expired - Fee Related
-
2001
- 2001-08-14 EP EP01962375A patent/EP1311247A4/en not_active Withdrawn
- 2001-08-14 AU AU2001283563A patent/AU2001283563A1/en not_active Abandoned
- 2001-08-14 US US09/929,838 patent/US6645524B2/en not_active Expired - Fee Related
- 2001-08-14 WO PCT/US2001/041712 patent/WO2002013794A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1311247A4 (en) | 2006-05-10 |
WO2002013794A1 (en) | 2002-02-21 |
US6645524B2 (en) | 2003-11-11 |
US20020098232A1 (en) | 2002-07-25 |
EP1311247A1 (en) | 2003-05-21 |
US6500457B1 (en) | 2002-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001283563A1 (en) | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent | |
AU4334700A (en) | Pharmaceutical dosage form for pulsatile delivery of methylphenidate | |
HUP0302319A3 (en) | Pharmaceutical composition for oral administration of active ingredient | |
PL356358A1 (en) | Solid dosage form of someticone for oral administration | |
AU2002216701A1 (en) | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs | |
AU2513900A (en) | Drug dosage unit for buccal administration of steroidal active agents | |
HK1047231A1 (en) | Oral pharmaceutical forms of administration with adelayed action with tramadol | |
AU2002357012A1 (en) | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof | |
MXPA03006476A (en) | Pharmaceutical dosage forms of epothilones for oral administration. | |
AU2879100A (en) | Formulation and system for intra-oral delivery of pharmaceutical agents | |
PL370889A1 (en) | Vaginal delivery of drugs | |
IL161214A0 (en) | Compositions for delivery of drug combinations | |
EP1246608A4 (en) | Pharmaceutical formulations for the delivery of drugs having low aqueous solubility | |
IL149186A0 (en) | Pharmaceutical compositions providing enhanced drug concentrations | |
MXPA02003596A (en) | Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation. | |
AU2623600A (en) | Compact dosage unit for buccal administration of a pharmacologically active agent | |
AU2001226029A1 (en) | Pharmaceutical formulation and method for pulmonary and oral delivery | |
AU2001234114A1 (en) | Drugs containing combined active ingredients | |
IL145559A0 (en) | Tolperison-containing pharmaceutical preparation for oral administration | |
AU2001238346A1 (en) | Modification of biopolymers for improved drug delivery | |
AU2001258395A1 (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
AU3945501A (en) | Apparatus for dosage of medicaments | |
IL162385A (en) | Benzothiazole - and benzoxazole - 4,7 - dione derivatives, uses thereof for the preparation of a medicament, medicaments containing them and pharmaceutical compositions containing them | |
AU5072000A (en) | Pharmaceutical composition for nasally administering water-soluble active substances | |
AU2001260089A1 (en) | Pharmaceutical compositions comprising desglymidodrine as an active drug substance |